Blueprint Medic CVR Common Stock Contra Cusip

13F holders, Q1 2026 (March 31)
4holders −2
1new positions
3sold out
$0.00avg. 13F price*

At the end of Q1 2026, 4 institutions reported holding Blueprint Medic CVR Common Stock Contra Cusip in their 13F filings, down 2 from Q4 2025. 1 opened new positions and 3 sold out. The largest holders were MassMutual Private Wealth & Trust, FSB ($0), Private Trust Co. NA ($0) and Ascentis Independent Advisors ($0).

Company
Blueprint Medic CVR Common Stock Contra Cusip
CUSIP
096CVR048
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q3 2025: 7Q3 2025Q4 2025: 6Q4 2025Q1 2026: 4Q1 2026Q2 2026: 3Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions1$0
Exits3$0

All 13F filers, Q4 2025 → Q1 2026: 11 shares bought and 1,014 shares sold, net −1,003 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

MassMutual Private Wealth & Trust, FSB 0.00% No change 9 $0
Private Trust Co. NA 0.00% No change 1 $0
Ascentis Independent Advisors 0.00% New 11 $0
Keating Financial Advisory Services, Inc. 0.00% No change 4 $0

"% of holder's portfolio" is BLUEPRINT MEDIC CVR COMMON STOCK CONTRA CUSIP's weight in each manager's 13F, not the share of Blueprint Medic CVR Common Stock Contra Cusip the manager owns.